201 related articles for article (PubMed ID: 18044981)
1. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.
Björklund P; Akerström G; Westin G
PLoS Med; 2007 Nov; 4(11):e328. PubMed ID: 18044981
[TBL] [Abstract][Full Text] [Related]
2. The internally truncated LRP5 receptor presents a therapeutic target in breast cancer.
Björklund P; Svedlund J; Olsson AK; Akerström G; Westin G
PLoS One; 2009; 4(1):e4243. PubMed ID: 19158955
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors.
Björklund P; Akerström G; Westin G
J Clin Endocrinol Metab; 2007 Jan; 92(1):338-44. PubMed ID: 17047023
[TBL] [Abstract][Full Text] [Related]
4. Activated beta-catenin in the novel human parathyroid tumor cell line sHPT-1.
Björklund P; Akerström G; Westin G
Biochem Biophys Res Commun; 2007 Jan; 352(2):532-6. PubMed ID: 17126301
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T
Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020
[TBL] [Abstract][Full Text] [Related]
6. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
7. Aberrant WNT/β-catenin signaling in parathyroid carcinoma.
Svedlund J; Aurén M; Sundström M; Dralle H; Akerström G; Björklund P; Westin G
Mol Cancer; 2010 Nov; 9():294. PubMed ID: 21078161
[TBL] [Abstract][Full Text] [Related]
8. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.
Romero G; Sneddon WB; Yang Y; Wheeler D; Blair HC; Friedman PA
J Biol Chem; 2010 May; 285(19):14756-63. PubMed ID: 20212039
[TBL] [Abstract][Full Text] [Related]
10. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
11. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
12. Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis.
Lam AP; Herazo-Maya JD; Sennello JA; Flozak AS; Russell S; Mutlu GM; Budinger GR; DasGupta R; Varga J; Kaminski N; Gottardi CJ
Am J Respir Crit Care Med; 2014 Jul; 190(2):185-95. PubMed ID: 24921217
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
14. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
[TBL] [Abstract][Full Text] [Related]
15. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
16. Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.
Björklund P; Lindberg D; Akerström G; Westin G
Mol Cancer; 2008 Jun; 7():53. PubMed ID: 18541010
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein receptor-related protein 5 (LRP5) expression in human osteoarthritic chondrocytes.
Papathanasiou I; Malizos KN; Tsezou A
J Orthop Res; 2010 Mar; 28(3):348-53. PubMed ID: 19810105
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.
Ettenberg SA; Charlat O; Daley MP; Liu S; Vincent KJ; Stuart DD; Schuller AG; Yuan J; Ospina B; Green J; Yu Q; Walsh R; Li S; Schmitz R; Heine H; Bilic S; Ostrom L; Mosher R; Hartlepp KF; Zhu Z; Fawell S; Yao YM; Stover D; Finan PM; Porter JA; Sellers WR; Klagge IM; Cong F
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15473-8. PubMed ID: 20713706
[TBL] [Abstract][Full Text] [Related]
19. The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.
Bryja V; Andersson ER; Schambony A; Esner M; Bryjová L; Biris KK; Hall AC; Kraft B; Cajanek L; Yamaguchi TP; Buckingham M; Arenas E
Mol Biol Cell; 2009 Feb; 20(3):924-36. PubMed ID: 19056682
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/β-catenin pathway.
Hua Y; Yang Y; Li Q; He X; Zhu W; Wang J; Gan X
J Biol Chem; 2018 Dec; 293(51):19710-19724. PubMed ID: 30361437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
